Bioniche Life Sciences Inc.

Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform.
Biotech Week; 12/9/2009; 568 words; Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian...intellectual property portfolio of MCC technology. Keywords: Bioniche Life Sciences Inc., Biopharmaceuticals, Drugs, Therapies, Pharmaceuticals...

Bioniche Reports Fiscal 2010 First Quarter Results and Achievement of First Milestone Under Licensing Agreement.
Cancer Vaccine Week; 11/16/2009; 1229 words; Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian...stated Graeme McRae, Chairman, President & CEO of Bioniche Life Sciences Inc. "The signing of a licensing agreement with Endo Pharmaceuticals...

Bioniche Reports Fiscal 2010 First Quarter Results And Achievement of First Milestone Under Licensing Agreement.
PR Newswire; 11/6/2009; 3534 words; ...ON, Nov. 6 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology...Graeme McRae, Chairman, President & CEO of Bioniche Life Sciences Inc. "The signing of a licensing agreement with...

Other News To Note.
BIOWORLD Today; 11/4/2009; 3316 words; ...system at the outset. o Bioenvision Inc., of New York, received $1...under the trade name Vetoryl. o Bioniche Life Sciences Inc., of Belleville, Ontario, closed...balance is expected within 90 days. Bioniche said it plans to use 38 percent...

Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 899 words; ...legal affairs. Barrier Therapeutics Inc., of Princeton, N.J., said...subsidiary. BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed...operations and chief medical officer. Bioniche Life Sciences Inc., of Belleville, Ontario, appointed...